Two Sigma Securities’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.08M | Buy |
+15,040
| New | +$1.16M | 0.13% | 196 |
|
|
2025
Q4 | – | Sell |
-5,054
| Closed | -$381K | – | 1576 |
|
|
2025
Q3 | $381K | Buy |
+5,054
| New | +$346K | 0.06% | 473 |
|
|
2025
Q2 | – | Sell |
-15,998
| Closed | -$1.08M | – | 1605 |
|
|
2025
Q1 | $1.08M | Buy |
+15,998
| New | +$957K | 0.16% | 138 |
|
|
2024
Q4 | – | Sell |
-109,469
| Closed | -$6.14M | – | 1980 |
|
|
2024
Q3 | $6.88M | Sell |
109,469
-63,961
| -37% | -$3.73M | 0.12% | 211 |
|
|
2024
Q2 | $10.2M | Buy |
173,430
+169,189
| +3,989% | +$10.6M | 0.12% | 204 |
|
|
2024
Q1 | $338K | Sell |
4,241
-104,057
| -96% | -$7.95M | ﹤0.01% | 1863 |
|
|
2023
Q4 | $8.55M | Sell |
108,298
-74,820
| -41% | -$5.33M | 0.08% | 233 |
|
|
2023
Q3 | $12.8M | Buy |
183,118
+44,011
| +32% | +$3.12M | 0.14% | 153 |
|
|
2023
Q2 | $9.62M | Buy |
+139,107
| New | +$9.9M | 0.14% | 153 |
|
|
2023
Q1 | – | Sell |
-2,939
| Closed | -$246K | – | 2775 |
|
|
2022
Q4 | $274K | Sell |
2,939
-7,162
| -71% | -$691K | 0.01% | 1618 |
|
|
2022
Q3 | $963K | Sell |
10,101
-10,081
| -50% | -$998K | 0.03% | 663 |
|
|
2022
Q2 | $1.87M | Sell |
20,182
-9,040
| -31% | -$882K | 0.07% | 326 |
|
|
2022
Q1 | $2.96M | Buy |
29,222
+26,844
| +1,129% | +$2.82M | 0.1% | 248 |
|
|
2021
Q4 | $245K | Buy |
+2,378
| New | +$220K | 0.01% | 941 |
|
|
2021
Q3 | – | Sell |
-3,967
| Closed | -$332K | – | 1621 |
|
|
2021
Q2 | $331K | Buy |
3,967
+563
| +17% | +$46.1K | 0.01% | 911 |
|
|
2021
Q1 | $256K | Buy |
+3,404
| New | +$248K | 0.01% | 511 |
|
|
2020
Q4 | – | Sell |
-9,606
| Closed | -$625K | – | 1715 |
|
|
2020
Q3 | $561K | Buy |
9,606
+4,264
| +80% | +$265K | 0.01% | 546 |
|
|
2020
Q2 | $347K | Buy |
+5,342
| New | +$336K | 0.01% | 804 |
|
|
2019
Q4 | – | Sell |
-5,365
| Closed | -$377K | – | 2380 |
|
|
2019
Q3 | $338K | Buy |
+5,365
| New | +$318K | ﹤0.01% | 1455 |
|
|
2019
Q2 | – | Sell |
-12,072
| Closed | -$650K | – | 2125 |
|
|
2019
Q1 | $651K | Buy |
12,072
+7,418
| +159% | +$458K | 0.01% | 761 |
|
|
2018
Q4 | $305K | Sell |
4,654
-4,720
| -50% | -$352K | ﹤0.01% | 1356 |
|
|
2018
Q3 | $738K | Sell |
9,374
-18,153
| -66% | -$1.3M | ﹤0.01% | 1183 |
|
|
2018
Q2 | $1.77M | Sell |
27,527
-604
| -2% | -$39.8K | 0.01% | 1005 |
|
|
2018
Q1 | $1.75M | Buy |
28,131
+13,409
| +91% | +$962K | 0.01% | 942 |
|
|
2017
Q4 | $1.07M | Buy |
+14,722
| New | +$1.07M | 0.03% | 406 |
|
|
2017
Q3 | – | Sell |
-4,239
| Closed | -$341K | – | 968 |
|
|
2017
Q2 | $341K | Buy |
4,239
+1,606
| +61% | +$127K | 0.06% | 312 |
|
|
2017
Q1 | $207K | Sell |
2,633
-12,578
| -83% | -$1M | 0.04% | 639 |
|
|
2016
Q4 | $1.2M | Buy |
15,211
+8,624
| +131% | +$698K | 0.4% | 39 |
|
|
2016
Q3 | $586K | Buy |
+6,587
| New | +$622K | 0.2% | 130 |
|
|
2015
Q3 | – | Sell |
-17,234
| Closed | -$1.81M | – | 230 |
|
|
2015
Q2 | $1.81M | Buy |
+17,234
| New | +$1.76M | 3.02% | 4 |
|
Other funds holding CVS
VCM
VPM
Two Sigma Securities's CVS Position: Q1 2026 in Review
Two Sigma Securities opened a new position in CVS Health (CVS) in Q1 2026: 15,040 shares worth $1.08M. The stake represents 0.13% of the portfolio and ranks #196 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in CVS as recently as Q3 2025.
Two Sigma Securities first reported a position in CVS in Q2 2015 and has held it in 30 quarters since. The position peaked at $12.8M in Q3 2023. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Two Sigma Securities held 15,040 shares of CVS Health worth $1.08M as of Q1 2026.
- CVS Health was a new Two Sigma Securities position in Q1 2026.
- CVS Health made up 0.13% of Two Sigma Securities's portfolio in Q1 2026, its #196 holding.
- Two Sigma Securities first reported a position in CVS Health in Q2 2015 and has held it in 30 quarters since.
- Two Sigma Securities's CVS Health position peaked at $12.8M in Q3 2023.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.